Table 5.
Reference | Study Design | Sample Population | Intervention | Control | Length of Treatment | Outcomes | Direction of Evidence | Reported Adverse Events |
---|---|---|---|---|---|---|---|---|
Jezova (2005) [67] | Randomized; Double-blind; Parallel Group |
29 healthy male subjects at the upper limit of the normal range of a trait anxiety scale1 | Mixture of L-lysine and L-arginine (3 g each/day) | Placebo | 10 days | AMino acid treatment enhanced adrenocorticotropic hormone, cortisol, adrenaline and noradrenaline levels and galvanic skin responses during stress; no effect on heart rate and blood pressure. | + | None |
Smriga (2007) [68] | Randomized; Double-blind; Parallel Group |
108 healthy Japanese adults | Oral L-lysine (2.64 g/day) and L-arginine (2.64 g/day) | Placebo | 1 week | L-lysine/L-arginine treatment significantly reduced trait and state anxiety; also decreased basal levels of salivary cortisol and chromogranin-A in male subjects | + | None |
STAI: State Trait Anxiety Inventory.
1. Scored above 45 on STAI questionnaire.